Cargando…

The impact of COVID-19 on the cascade of care of HCV in the US and China

Background and objectives: The COVID-19 pandemic imperiled the global health system. We aimed to determine the impact of COVID-19 on the care continuum of HCV-infected patients. Material and Methods: Two hundred and fifty-six patients who were prescribed a course of DAA therapy at three tertiary med...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yeo, Yee Hui, Gao, Xu, Wang, Jian, Li, Qingyu, Su, Xingyang, Geng, Yu, Huang, Rui, Wu, Chao, Ji, Fanpu, Sundaram, Vinay, Noureddin, Mazen, Buti, Maria, Ayoub, Walid S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Fundación Clínica Médica Sur, A.C. Published by Elsevier España, S.L.U. 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8857763/ https://www.ncbi.nlm.nih.gov/pubmed/35192964 http://dx.doi.org/10.1016/j.aohep.2022.100685

Ejemplares similares

Estrogen-Driven Growth of Focal Nodular Hyperplasia: Truth or Myth?
por: Ashhab, Ashraf A., et al.
Publicado: (2021)

Microbiome and bile acid profiles in duodenal aspirates from patients with liver cirrhosis: The Microbiome, Microbial Markers and Liver Disease Study
por: Jacobs, Jonathan P., et al.
Publicado: (2018)

Management of refractory ascites in cirrhosis: Are we out of date?
por: Annamalai, Alagappan, et al.
Publicado: (2016)

Evaluation of Trends in Alcohol Use Disorder–Related Mortality in the US Before and During the COVID-19 Pandemic
por: Yeo, Yee Hui, et al.
Publicado: (2022)

2510. Adapting the CDC HCV viral clearance cascade methodology for persons with HIV (PWH) and HCV co-infection in 5 Health Department Jurisdictions in the US
por: Wegener, Maximilian D, et al.
Publicado: (2023)

Insights on the Russian HCV care cascade: minimal HCV treatment for HIV/HCV co-infected PWID in St. Petersburg
por: Tsui, Judith I., et al.
Publicado: (2016)

Dietary Protein, Fiber and Coffee Are Associated with Small Intestine Microbiome Composition and Diversity in Patients with Liver Cirrhosis
por: Hussain, Shehnaz K., et al.
Publicado: (2020)

2941. Racial and Ethnic Disparities in the Care Cascade for Children with Perinatal Hepatitis C Virus (HCV) infection in the United States (US)
por: Rose Curtis, Megan, et al.
Publicado: (2023)

Duodenal Microbiome and Serum Metabolites Predict Hepatocellular Carcinoma in a Multicenter Cohort of Patients with Cirrhosis
por: Dong, Tien S., et al.
Publicado: (2021)

1483. Real-time Creation of HCV Treatment Cascades in Clinics to Improve HCV Treatment Rates Among Patients with HIV/HCV Co-infection
por: Wegener, Maximilian D, et al.
Publicado: (2023)

Impact of the COVID-19 pandemic on HCV elimination in Spain
por: Buti, Maria, et al.
Publicado: (2021)

932. Creating a Statewide HCV Treatment Cascade for HIV/HCV Co-Infected Persons Using a Partnership with DPH
por: Wegener, Maximilian D, et al.
Publicado: (2020)

Increase in Alcoholic Hepatitis as an Etiology for Liver Transplantation in the United States: A 2004–2018 Analysis
por: Noureddin, Nabil, et al.
Publicado: (2020)

Epidemiology of Hepatitis C Virus (HCV) Infection
por: Sy, Theodore, et al.
Publicado: (2006)

Psychiatrist-led treatment of hepatitis C (HCV) at an opioid agonist treatment (OAT) clinic in Stockholm - enhancing the HCV treatment care cascade
por: Kåberg, M., et al.
Publicado: (2022)

Nonalcoholic fatty liver disease prevalence and severity in Asian Americans from the national health and nutrition examination surveys 2017–2018
por: Truong, Emily, et al.
Publicado: (2022)

Current status of hepatocellular carcinoma detection: screening strategies and novel biomarkers
por: Ayoub, Walid S., et al.
Publicado: (2019)

Drug Authorization for Sofosbuvir/Ledipasvir (Harvoni) for Chronic HCV Infection in a Real-World Cohort: A New Barrier in the HCV Care Cascade
por: Do, Albert, et al.
Publicado: (2015)

Hepatitis Delta: Epidemiology, Diagnosis and Management 36 Years After Discovery
por: Noureddin, Mazen, et al.
Publicado: (2013)

Current and Potential Therapies Targeting Inflammation in NASH
por: Albhaisi, Somaya, et al.
Publicado: (2021)

Non-invasive imaging biomarkers for liver steatosis in non-alcoholic fatty liver disease: present and future
por: Alnimer, Lynna, et al.
Publicado: (2023)

Noninvasive Testing Using Magnetic Resonance Imaging Techniques as Outcomes in Nonalcoholic Steatohepatitis Clinical Trials: How Full Is the Glass?
por: Noureddin, Nabil, et al.
Publicado: (2020)

933. Cured vs. Not Yet Treated: Population Differences for HIV/HCV Co-infected Patients Navigating the HCV Care Cascade in 11 Connecticut Clinics
por: Brooks, Ralph P, et al.
Publicado: (2020)

Hepatitis C virus care cascade among people who inject drugs in puerto rico: Minimal HCV treatment and substantial barriers to HCV care
por: Aponte-Meléndez, Yesenia, et al.
Publicado: (2023)

Engagement with the HCV care cascade among high-risk groups: A population-based study
por: Erman, Aysegul, et al.
Publicado: (2023)

Optimizing Hepatitis C Virus (HCV) Treatment in a US Colocated HCV/Opioid Agonist Therapy Program
por: Habchi, Jackie, et al.
Publicado: (2020)

STELLAR 3 and STELLAR 4: Lessons from the fall of Icarus
por: Rinella, Mary E., et al.
Publicado: (2020)

Splenic CD4(+) and CD8(+) T-cells highly expressed PD-1 and Tim-3 in cirrhotic patients with HCV infection and portal hypertension
por: Huang, Na, et al.
Publicado: (2021)

Markerless Rat Behavior Quantification With Cascade Neural Network
por: Jin, Tianlei, et al.
Publicado: (2020)

Seroprevalence of HCV and HIV Infections by Year of Birth in Spain: Impact of US CDC and USPSTF Recommendations for HCV and HIV Testing
por: Mena, Alvaro, et al.
Publicado: (2014)

Looking Into the Crystal Ball: Predicting the Future Challenges of Fibrotic NASH Treatment
por: Alkhouri, Naim, et al.
Publicado: (2019)

Higher thresholds for the utilization of steatotic allografts in liver transplantation: Analysis from a U.S. national database
por: Steggerda, Justin A., et al.
Publicado: (2020)

Beyond the Checkpoint: Severe Axitinib-induced Liver Injury
por: Yeo, Yee Hui, et al.
Publicado: (2023)

Lifestyle and Hepatocellular Carcinoma What Is the Evidence and Prevention Recommendations
por: Zelber-Sagi, Shira, et al.
Publicado: (2021)

Review article: role of glucagon‐like peptide‐1 receptor agonists in non‐alcoholic steatohepatitis, obesity and diabetes—what hepatologists need to know
por: Barritt, A. Sidney, et al.
Publicado: (2022)

Trends of Cirrhosis-related Mortality in the USA during the COVID-19 Pandemic
por: Yeo, Yee Hui, et al.
Publicado: (2023)

Molecular Epidemiology of HCV Monoinfection and HIV/HCV Coinfection in Injection Drug Users in Liuzhou, Southern China
por: Tan, Yi, et al.
Publicado: (2008)

Effectiveness of HCV core antigen and RNA quantification in HCV-infected and HCV/HIV-1-coinfected patients
por: Long, Lu, et al.
Publicado: (2014)

Prevalence and characteristics of hepatitis C virus infection in Shenyang City, Northeast China, and prediction of HCV RNA positivity according to serum anti-HCV level: retrospective review of hospital data
por: Li, Yurong, et al.
Publicado: (2020)

Impact of COVID‐19 pandemic on HCV care cascade in Rwanda: Ecological study from July 2019 to June 2021
por: Makuza, Jean Damascene, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s432klb4rtko4cf2g7k6i24qd3